Center for Immunotherapy and Cell-Based Technologies

Novosibirsk — Kaliningrad — Moscow — Irkutsk
Main

Colorectal cancer

Xenovaccinotherapy for cancer

http://www.medicalnewstoday.com/rss/cancer-oncology.xmlhttp://www.medicalnewstoday.com/rss/immune_system.xmlhttp://www.medicalnewstoday.com/rss/multiple_sclerosis.xmlhttp://www.medicalnewstoday.com/rss/stem_cell_research.xml

  • docid_2.pageCache.php
  • docid_540.pageCache.php
  • docid_549.pageCache.php
  • docid_965.pageCache.php

28.08.2019 Lynch syndrome is a genetic condition that increases a person’s risk of developing colorectal cancer. Learn more about its symptoms, diagnosis, and tr...

22.07.2019 In the United States, colorectal cancer rates are rising in the under 50s. Also, diagnoses in younger adults are more likely to be of advanced disease...

05.05.2019 Researchers have revealed positive results of a small, early clinical trial that tested the effects of a new vaccine on 10 people with colorectal canc...

19.04.2019 A recent study concludes that when a person takes vitamin D alongside standard chemotherapy, it might reduce the growth rate of colorectal cancer....

04.03.2019 The common oral bacterium F. nucleatum hastens the aggressiveness of colorectal cancer by promoting the growth of cells that are already cancerous....

24.02.2019 According to a recent study, eating more allium vegetables, such as garlic and onions, might reduce the risk of developing colorectal cancer....

08.02.2019 Scientists have identified a number of synthetic cannabinoid compounds that can halt the growth of several types of human colorectal cancer cells....

06.02.2019 A new study links prolonged sitting while viewing TV to a higher risk of young-onset colorectal cancer, regardless of obesity and exercise....

08.01.2019 Researchers investigating a new biomarker for colorectal cancer have also uncovered a novel intervention that might help treat a range of cancer types...

26.12.2018 By combining two common cancer drugs, researchers have found a more effective way to treat colorectal cancer and reduce unpleasant side effects....


Immunotherapy for cancer

An active specific immunotherapy (vaccinotherapy) is a strategy using tumor-associated antigens for including antitumor immune responses. The small structural distinctions of the xenogenic tumor-associated antigens from their human analogues render these antigens highly immunogenic and capable of including immune-mediated, antitumor responses in a patient not only at early, but also at advanced stages of disease, when tumor-derived immunosuppression is significant. Tumor-specfic immunotherapy is able to generate a selective and long-term antitumor effect. Such a therapy has no complications attributable to chemotherapy.

Xenovaccinotherapy for cancer